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Summary
 
As a consequence of positive selection in the thymus, immature CD4
 
1
 
8
 
1
 
 double-positive,
[DP] thymocytes selectively terminate synthesis of one coreceptor molecule and, as a result,
differentiate into either CD4
 
1
 
 or CD8
 
1
 
 T cells. The decision by individual DP thymocytes to
terminate synthesis of one or the other coreceptor molecule is referred to as lineage commit-
ment. Previously, we reported that the intrathymic signals that induced commitment to the
CD4 versus CD8 T cell lineages were markedly asymmetric. Notably, CD8 commitment ap-
peared to require lineage-specific signals, whereas CD4 commitment appeared to occur in the
absence of lineage-specific signals by default. Consequently, it was unclear whether CD4 com-
mitment, as revealed by selective termination of CD8 coreceptor synthesis, occurred in all DP
thymocytes, or whether CD4 commitment occurred only in T cell receptor (TCR)–CD3-signaled
DP thymocytes. Here, we report that selective termination of CD8 coreceptor synthesis does
not occur in DP thymocytes spontaneously. Rather, CD4 commitment in DP thymocytes re-
 
quires signals transduced by either CD3 or 
 
z
 
 chains, which can signal CD4 commitment even
in the absence of clonotypic TCR chains.
 
I
 
mmature CD4
 
1
 
8
 
1
 
 (double-positive [DP])
 
1
 
 cells differen-
tiate in the thymus into mature CD4
 
1
 
8
 
2
 
 or CD4
 
2
 
8
 
1
 
(single-positive, SP) T cells by the process of positive selec-
tion. Consequently, positive selection of DP thymocytes
requires that synthesis of either CD4 or CD8 coreceptor
molecules be terminated, an event referred to as lineage
commitment. Several models of lineage commitment have
been proposed (1–13) and have been actively debated for
years. The instructional model of lineage commitment (1,
2) postulates that lineage-specific signals transduced by sur-
face coreceptor molecules, together with TCR signals, ter-
minate synthesis of the inappropriate coreceptor. The sto-
chastic/selection model (3–7) postulates that TCR-signaled
thymocytes randomly terminate synthesis of one or the other
coreceptor molecule, and, because such cells are short-lived,
they require a subsequent TCR signal to become long-
lived cells that can differentiate into maturity. Both the in-
structional and stochastic/selection models of lineage com-
mitment presume that identical rules govern CD4 commit-
ment and CD8 commitment with the only difference being
the identify of their target coreceptor molecule. In contrast,
the asymmetric commitment model (8) postulates that com-
mitment to the CD4 and CD8 lineages are consequences of
very different signaling events. That is, CD8 commitment
requires TCR and CD8-specific lineage signals, whereas
CD4 commitment results from the absence of CD8-spe-
cific lineage signals.
The asymmetric commitment model was originally based
on the molecular definition of lineage commitment in DP
thymocytes as the selective termination of synthesis of one
coreceptor molecule, and was prompted by experiments
assessing coreceptor synthesis in individual DP thymocytes.
By use of the coreceptor reexpression assay, we observed
that commitment of DP thymocytes to the CD8 lineage
(i.e., termination of CD4 synthesis) strictly required spe-
cific TCR recognition of intrathymic MHC class I deter-
minants. In contrast, we observed that commitment of DP
thymocytes to the CD4 lineage (i.e., termination of CD8
 
1
 
Abbreviations used in this paper:
 
 DN, double negative; DP, double positive;
SP, single positive; TSA, thymic shared antigen.
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synthesis) occurred in the absence of CD8 commitment,
whether or not MHC class II molecules were expressed in
the thymus (8). As a result, commitment to the CD4 lin-
eage did not require lineage-specific signals and so appeared
to be a default developmental pathway. Essentially identical
results were independently obtained examining in vitro
cultured thymocytes (13). Other in vitro studies attempting
to signal thymocyte differentiation in culture have similarly
found that the requirements for CD4
 
1
 
 T cell generation
are far less stringent than those for CD8
 
1
 
 T cell generation
(14–16). In addition to signaling asymmetries, there also
exist marked asymmetries in the phenotypic progression by
which immature thymocytes differentiate into CD4
 
1
 
 ver-
sus CD8
 
1
 
 T cells in vivo (17–19).
Recently, we determined that DP thymocytes that have
undergone lineage commitment have a distinct phenotype
relative to the majority of DP thymocytes that have not yet
undergone lineage commitment. We found that all lin-
eage-committed DP thymocytes, including those commit-
ted to the CD4 lineage, were CD5
 
hi
 
CD69
 
hi
 
 and so had
presumably experienced a TCR signaling event in the thy-
mus, indicating that TCR–CD3 signaling was involved in
thymocyte commitment to either T cell lineage (20). The
present study was undertaken specifically to determine
whether or not TCR–CD3 signals were required to induce
lineage commitment in immature DP thymocytes. In par-
ticular, we wished to assess whether CD4 commitment, as
revealed by selective termination of CD8 coreceptor syn-
thesis in DP thymocytes, was dependent on TCR–CD3
signaling or whether it occurred spontaneously in imma-
ture DP thymocytes.
 
Materials and Methods
 
Animals.
 
All mice were housed and bred in a specific pathogen-
free facility and used at 4–12 wk of age. TCR
 
a8
 
 mice (21) were
obtained from The Jackson Laboratory (Bar Harbor, ME). TCR
 
z8
 
mice (22) were mated with RAG2
 
8
 
 mice (23) to generate dou-
ble-deficient RAG2
 
8
 
TCR
 
z8
 
 mice. Mice transgenic for a chimeric
protein consisting of the extracellular and transmembrane do-
mains of human CD25 and the cytosolic domain of murine
TCR
 
z
 
 (TT
 
z
 
, line no. 35) (24) were also bred onto the RAG2
 
8
 
background to make RAG
 
8
 
–TT
 
z
 
 mice.
 
Generation of DP Thymocytes in RAG2
 
8
 
 Mice.
 
RAG2
 
8
 
 and
RAG2
 
8z8
 
 mice were injected intraperitoneally with 250 
 
m
 
g of af-
finity-purified anti-CD3
 
e
 
 mAb (145-2C11) (25) or with the dose
indicated. RAG
 
8
 
–TT
 
z
 
 mice were injected with 250 
 
m
 
g anti-Tac
mAb (1HT4-4H3). 8 d after injection, thymocytes were obtained
and analyzed by flow cytometry. Where indicated, RAG2
 
8
 
 mice
were injected with 250 
 
m
 
g of affinity-purified anti-CD3
 
e
 
 mAb
on both day 0 and day 8 and then subjected to the coreceptor re-
expression assay on day 12. Where indicated, RAG2
 
8
 
 mice were
radiated with 400 cGy and analyzed 3 wk later (26, 27).
 
Cell Sorting and Coreceptor Reexpression Assay.
 
Performance of the
coreceptor reexpression assay on electronically sorted thymocyte
populations has been described previously (8). In brief, single cell
suspensions of thymocytes were stained with PE-conjugated anti-
CD4 mAb (GK1.5; Becton Dickinson, San Jose, CA) and FITC-
conjugated anti-CD8 mAb (53-6-72, Becton Dickinson). Stained
thymocytes were electronically sorted by a FACstar
 
Ò
 
 Plus accord-
ing to the gates indicated in each figure. Sorted cells were washed
extensively with PBS and treated with 0.04% pronase (Calbio-
chem Novabiochem, San Diego, CA) and 100 
 
m
 
g/ml DNase I
(Boehringer Mannheim, Indianapolis, IN) at 37
 
8
 
C for 15 min,
pelleted, and pronase treated for another 10 min at 37
 
8
 
C. Cells
were placed in culture for 12–16 h of culture at either 4 or 37
 
8
 
C,
after which harvested cells were restained with anti-CD4–PE and
anti-CD8–FITC. For three-color analysis cells were also stained
with anti-CD5 (53-7-3; PharMingen) followed by Cy-5 avidin
(Caltag, San Francisco, CA). Dead cells were excluded by elec-
tronic gating on both forward light scatter and propidium iodide
intensity. Flow cytometry using three- or four-decade logarith-
mic amplification as indicated was performed on a FACStar
 
Ò
 
 Plus
and data were analyzed using software designed by the Division
of Computer Research and Technology at the National Institutes
of Health.
 
Results
 
To assess the possibility that DP thymocytes spontane-
ously terminated CD8 coreceptor synthesis even in the ab-
sence of TCR–CD3 signals, we examined DP thymocytes
from TCR
 
a8
 
 mice by the coreceptor reexpression assay.
TCR
 
a8
 
 thymocytes cannot express conventional 
 
ab
 
 TCR
complexes and, consequently, cannot differentiate beyond
the DP stage of development (21). To enrich for DP thy-
mocytes that might have committed to the CD4 or CD8
T cell lineages, we electronically sorted for CD4
 
1
 
8
 
lo
 
 and
CD4
 
lo
 
8
 
1
 
 transitional cell populations and utilized the core-
ceptor reexpression assay to determine the coreceptor mol-
ecules they were actively synthesizing (Fig. 1, 
 
A
 
 and 
 
B
 
). In
the coreceptor reexpression assay, preexisting surface CD4
and CD8 coreceptor molecules are removed from the
sorted cells by treatment with low doses of pronase, and the
stripped cells then placed into single cell suspension cul-
tures for 14 h. Metabolic activity of cultured cells is inhib-
ited at 4
 
8
 
C, so that cell surface coreceptor reexpression
does not occur (Fig. 1 
 
A
 
 and 
 
B
 
, 
 
middle columns
 
). However,
cells cultured at 37
 
8
 
C do reexpress the CD4 and/or CD8
coreceptor molecules that they are actively synthesizing.
Indeed, we have previously demonstrated that coreceptor
reexpression in this assay requires active coreceptor tran-
scription and protein synthesis (8). Interestingly, virtually
all CD4
 
1
 
8
 
lo
 
 sorted cells from TCR
 
a8
 
 DP thymocytes reex-
pressed both CD4 and CD8 coreceptors and so reappeared
as DP cells (Fig. 1 
 
A
 
, 
 
top
 
). Identical results were obtained
with CD4
 
lo
 
8
 
1
 
 sorted cells from TCR
 
a8
 
 mice (Fig. 1 
 
B
 
, 
 
top
 
).
That is, none of the DP thymocytes present in TCR
 
a8
 
mice had selectively terminated either CD4 or CD8 core-
ceptor synthesis, indicating that none had undergone lin-
eage commitment. Thus, these results indicated that lineage
commitment did not occur spontaneously in immature DP
thymocytes but might be dependent upon signals trans-
duced by surface TCR–CD3 complexes.
To assess directly the role of TCR–CD3 signals in in-
ducing lineage commitment in DP thymocytes, we assessed
DP thymocytes from experimentally induced RAG2
 
8
 
 mice.
RAG2
 
8
 
 mice fail to express any clonotypic TCR chain be-
cause they are unable to recombine any TCR gene locus. 
19
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As a result, RAG2
 
8
 
 thymocytes are arrested at the CD4
 
2
 
8
 
2
 
(double-negative, DN) stage of development (23). How-
ever, RAG
 
8
 
 thymocytes can be induced to differentiate
further into DP cells by either sublethal 
 
g
 
-irradiation (26,
27) or by injection of anti-CD3
 
e
 
 mAb (28, 29) (Fig. 1, 
 
A
 
and 
 
B
 
, 
 
left column
 
). Induced RAG
 
8
 
 DP thymocytes did not
further differentiate into phenotypically mature T cells as
thymocytes from stimulated RAG
 
8
 
 mice that appeared
CD4
 
1
 
8
 
2
 
 or CD4
 
2
 
8
 
1
 
 (Fig. 1, 
 
A
 
 and 
 
B
 
, 
 
left columns
 
) were
predominantly precursor cells that spontaneously became
CD4181 in overnight culture (data not shown; reference
30). Even though sublethal g-irradiation and anti-CD3e
injection both induced generation of RAG8 DP thy-
mocytes (Fig. 1), the two modes of stimulation did not
have identical effects. That is, sublethal g-irradiation did
not detectably stimulate CD3 signal transduction as re-
vealed by the absence of CD5 upregulation, whereas injec-
tion of anti-CD3e mAb did stimulate CD3 signal transduc-
tion and CD5 upregulation (Fig. 2). Assessment of CD418lo
and CD4lo81 sorted cells from g-irradiated RAG28 mice
by the coreceptor reexpression assay revealed that none had
undergone lineage commitment (Fig. 1, A and B). In con-
trast, assessment of CD418lo sorted cells from anti-CD3e–
induced RAG28 mice revealed the presence of CD4-com-
mitted DP thymocytes that had selectively terminated CD8
coreceptor synthesis, as well as the presence of uncommit-
ted DP thymocytes (Fig. 1 A). The CD4-committed thy-
mocytes that were present in anti-CD3e–induced RAG28
Figure 1. Lineage commitment in sorted CD418lo and CD4lo81 thymocytes from experimental mice. Purified populations of CD418lo thymocytes (A)
and CD4lo81 thymocytes (B) were obtained by electronic cell sorting according to the indicated sorting gates superimposed on the starting thymocyte
populations (left columns). Sorted thymocyte populations were stripped of surface coreceptor molecules by treatment with low doses of pronase, after
which they were placed in suspension cultures at 48C (middle panels) or 378C (right panels) for 12–16 h and restained for CD4 and CD8 surface expression.
The coreceptor reexpression assay detects the coreceptor molecules that individual thymocytes synthesized during the 378C culture, and is dependent
upon new transcription and new protein synthesis (8). Sorted thymocytes that reexpress both CD4 and CD8 coreceptor proteins are lineage-uncommit-
ted cells; those reexpressing only CD4 are CD4 committed; and those reexpressing only CD8 are CD8 committed. Cells cultured at 48C do not reexpress
surface coreceptor molecules so that their CD4–CD8 histograms reflect whatever coreceptor molecules that potentially remain after pronase treatment
(middle columns). As we have previously described (8), the anti-CD4 mAb used to prepare thymocytes for cell sorting minimally interferes with stripping
of surface CD4 molecules by pronase, resulting in a small number of residual CD4 molecules remaining on the cell surface. Consequently, to highlight
changes in coreceptor reexpression during 378C cultures, histogram boxes were drawn based on the 48C profiles of each sorted and pronase-stripped cell
population. The frequency of cells in each box is indicated. The number of the thymocytes obtained in these experimental mice were the following:
TCRa8 (9 3 107 cells), g-irradiated RAG28 (4 3 107 cells), anti-CD3e mAb–injected RAG28 (1.1 3 108 cells), anti-CD3e mAb–injected
RAG8TCRz8 (8 3 107 cells), and anti-Tac mAb–injected RAG8–TTz (4 3 107 cells).20 CD3 Signaling in CD4 Commitment
mice expressed the phenotype of newly committed thy-
mocytes in that they were HSAhi, thymic shared antigen
(TSA)-1hi (data not shown). In contrast, anti-CD3e–induced
RAG28 thymocytes had no CD8-committed cells among
either CD418lo or CD4lo81 sorted cell populations (Fig. 1,
A and B). Thus, these results (a) confirm that DP thy-
mocytes do not undergo lineage commitment in the ab-
sence of TCR–CD3 signals, and (b) demonstrate that CD3
signals stimulated by anti-CD3e mAbs are sufficient to in-
duce DP thymocytes to selectively terminate CD8 core-
ceptor synthesis and commit to the CD4 lineage, even in
the absence of clonotypic TCR chains.
To determine whether signals transduced by TCRz chains
are indispensable for induction of CD4 commitment, we
generated double knockout RAG28TCRz8 mice. In vivo
injection of anti-CD3e mAbs into RAG8TCRz8 double
knockout mice induced the generation of DP thymocytes,
as has been described (31), and signaled these cells to upregu-
late CD5 expression (Fig. 2). Interestingly, we found that
CD418lo sorted thymocytes from these anti-CD3e–injected
mice did contain CD4-committed cells that had selectively
terminated CD8 coreceptor synthesis (see Fig. 1 A). In
contrast, no CD8-committed cells were detected in either
CD418lo or CD4lo81 sorted cell populations (Fig. 1, A and
B). These results demonstrate that CD3-transduced signals
can induce CD4 commitment in DP thymocytes in the ab-
sence of clonotypic TCR chains and in the absence of
TCRz chains.
To determine whether signals transduced by TCRz
chains were able to induce CD4 commitment, we assessed
lineage commitment in DP thymocytes from RAG28 mice
that expressed a chimeric transgenic protein consisting of
the external and transmembrane domains of human CD25
and the cytosolic domains of TCRz (24). The extracellular
domain of this transgenic protein is recognized by anti-Tac
mAb. Injection of anti-Tac mAb into RAG8–TTz mice
induced the generation of DP thymocytes (Fig. 1 A), as
previously reported (24), and signaled them to upregulate
CD5 expression (Fig. 2). We then assessed DP thymocytes
from anti-Tac–induced RAG8–TTz mice for the presence
of lineage committed cells. We found that CD418lo sorted
thymocytes from these mice did contain CD4-committed
cells, but did not contain any CD8-committed cells in ei-
ther CD418lo or CD4lo81 sorted cell populations (see Fig.
1, A and B). These results demonstrate that signals trans-
duced by the cytosolic portion of TCRz chains are suffi-
cient to induce DP thymocytes to selectively terminate
CD8 coreceptor synthesis and to undergo CD4 commit-
ment.
Next, we wished to evaluate the relationship between
CD5 upregulation and CD4 commitment in anti-CD3e–
signaled RAG28 thymocytes. In vivo injection of a single
dose of either 10 or 250 mg of anti-CD3e mAb–induced
substantial numbers of DP thymocytes in RAG8 mice when
assayed 8 d later (Fig. 3). While both injection doses in-
duced differentiaton to the DP stage, we reasoned that only
the high dose might persist long enough in vivo to stimulate
a subsequent CD3 signal after DP thymocytes appeared. In-
deed, only DP thymocytes from high dose injected animals
had upregulated CD5 expression, and only DP thymocytes
from high dose injected animals contained CD4-commit-
ted thymocytes (Fig. 3). DP thymocytes from low dose in-
jected animals were CD5lo and remained uncommitted
(Fig. 3). We conclude that CD4 commitment requires
CD3 signals in DP thymocytes that are of sufficient inten-
sity to upregulate surface CD5 expression.
Finally, having observed that a single injection of anti-
body was sufficient to stimulate CD3 or TCRz chains to
transduce signals that upregulated CD5 surface expression
and induced CD4 commitment but not CD8 commit-
ment, we assessed whether CD8-committed cells might
appear in RAG28 thymi upon antibody restimulation. In
Fig. 4, RAG28 mice were injected with anti-CD3e mAb
on both days 0 and 8, and then assessed 4 d later on day 12.
Thymocytes were sorted into CD418lo and CD4lo81 pop-
Figure 2. CD5 surface expression on thymocytes from experimental
mice. Thymocytes from the indicated experimental mice were stained
with anti-CD5 mAb (solid line) or an irrelevant antibody (shaded curve).
CD5 expression on normal B6 thymocytes stained at the same time as a
positive control is also shown for comparison (dotted line).21 Suzuki et al.
ulations and then assessed for coreceptor synthesis by the
coreceptor reexpression assay. We found that CD418lo thy-
mocytes contained CD4-committed cells that had selec-
tively terminated CD8 coreceptor synthesis (Fig. 4, middle
row), but neither sorted population contained CD8-com-
mitted cells (Fig. 4, middle and bottom rows). Thus, CD8-
committed cells did not appear in RAG28 thymi despite a
second antibody injection and despite assessment on day 12
after the initial injection of antibody (Fig. 4). Indeed, we
also failed to detect CD8-committed thymocytes on days
28 and 35 after antibody injection (data not shown).
Discussion
The present study demonstrates that immature DP thy-
mocytes do not spontaneously terminate synthesis of either
CD4 or CD8 coreceptor molecules. Rather, selective termi-
nation of coreceptor synthesis by immature DP thymocytes
requires signals transduced by either CD3 or TCRz chains,
and can occur in signaled DP thymocytes that lack clono-
typic TCR chains. Interestingly, CD3-signaled DP thy-
mocytes upregulated CD5 expression and selectively termi-
nated CD8 coreceptor synthesis, but did not selectively
terminate CD4 coreceptor synthesis. Thus, CD4 commit-
ment is induced in DP thymocytes by CD3 signals that are
of sufficient intensity to upregulate CD5 expression.
The results of the present study are not readily compati-
ble with either instructional (1, 2) or stochastic/selection
(3–7) models of lineage commitment. That is, the instruc-
tional model cannot explain the presence of any lineage-
committed RAG28 thymocytes in response to lineage-neu-
tral CD3 and TCRz signals, whereas the stochastic/selection
model cannot explain why CD3 and TCRz signals only
induced RAG28 thymocytes to become CD4 committed
without inducing an equal number to become CD8 com-
mitted. In contrast with these two models of lineage com-
mitment, the present results are concordant with the asym-
metric commitment model of lineage commitment (8, 13).
That is, our results are consistent with the concept that CD4
commitment, unlike CD8 commitment, can occur in the
absence of lineage-specific signals. Importantly, the present
results extend the asymmetric commitment model by dem-
onstrating that CD4 commitment does not occur sponta-
neously in unsignaled DP thymocytes, but rather is induced
Figure 3. Correlation between
induction of CD4 commitment
and surface CD5 upregulation.
RAG8 mice received one intrap-
eritoneal injection of either 250 mg
or 10 mg of affinity-purified anti-
CD3e mAb. 8 d later, thymocytes
were sorted according to the indi-
cated gates and assessed for lineage
commitment by the coreceptor
reexpression assay (left panels).
Unsorted thymocytes were placed
in culture for 12 h at 48C, at
which temperature thymocyte
phenotype is stable, and then as-
sessed for surface CD5 expression
(right panels). Solid line indicates
CD5 expression on experimental
thymocytes. Shaded curve repre-
sents negative control staining of experimental thymocytes with an irrelevant mAb. The dotted line represents CD5 expression on normal B6 thymocytes
stained at the same time as a positive control and is shown for comparison. The number of thymocytes obtained on day 8 were 1–1.5 3 108 cells and
3–4 3 107 cells with the injection of 250 mg and 10 mg, respectively.
Figure 4. CD8-committed thymocytes do not appear in RAG28 thymi
even after two injections of anti-CD3 mAb. RAG28 mice were injected
with 250 mg of affinity-purified anti-CD3e mAb on both day 0 and 8.
On day 12, thymocytes were harvested, sorted into CD418lo and
CD4lo81 populations, and assessed by the coreceptor reexpression assay
for appearance of CD4-committed and CD8-committed cells. Numbers
in each box represent the frequency of thymocytes falling in that box.22 CD3 Signaling in CD4 Commitment
by lineage-neutral signals transduced by CD3 and/or TCRz
chains.
Importantly, we found that CD3 signaling did not in-
duce all DP thymocytes in the present study to become
CD4 committed, as only a small minority of CD3-signaled
RAG28 thymocytes terminated CD8 coreceptor synthesis,
even though all DP thymocytes had upregulated CD5 surface
expression. This observation is consistent with our recent
finding that only a small fraction of CD5hi DP thymocytes
in normal mice have undergone lineage commitment, with
most CD5hi DP thymocytes remaining lineage uncommit-
ted (20). Our current perspective is that CD3 signaling
drives CD5lo DP thymocytes to become CD5hi, at which
point they developmentally await the induction of lineage-
specific signals. If lineage-specific signals are generated,
perhaps by Notch proteins (12), CD5hi DP thymocytes ter-
minate CD4 coreceptor synthesis and become CD8 com-
mitted. But if lineage-specific signals are not generated,
CD5hi DP thymocytes terminate CD8 coreceptor synthesis
and become CD4 committed. We do not know how long
CD5hi DP thymocytes await the appearance of lineage-spe-
cific signals before terminating CD8 coreceptor synthesis,
and we do not know whether there are intrathymic signals
that regulate the timing of this event.
Finally, the present results are remarkable in their dem-
onstration that CD3-signaled DP thymocytes could un-
dergo CD4 commitment even in the absence of clonotypic
TCR chains. Of course, DP thymocytes express surface
molecules in addition to clonotypic TCR chains that can
stimulate CD3 signaling, such as CD2, CD5, Thy-1, and
Ly6 (32–34). Consequently, it is conceivable that engage-
ment of such nonclonotypic molecules by intrathymic ligands
can inefficiently mimic clonotypic TCR chains in their
ability to stimulate CD3 signals that induce CD5lo DP thy-
mocytes to become CD5hi, and so eventually to become
CD4 committed. The absence of CD5hi DP thymocytes and
CD4-committed cells in TCRa8 mice does not rule out in-
trathymic signaling by nonclonotypic molecules because
surface CD3 expression is probably too low on TCRa8
thymocytes to transduce such signals. Indeed, stimulation
of CD3 signals by nonclonotypic receptors may provide one
explanation for the appearance of small numbers of CD4-
committed DP thymocytes in MHC-deficient thymi (8).
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